InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Jazz Pharmaceuticals plc

JAZZ Clue Score41
Ireland Fiscal year ends December CIK 0001232524
$218.42 -1.81% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $218.42 +59.80% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue1.49Operating income0.59Net income0.40EPS, diluted6.41Fiscal year 2017Revenue1.62 +8.8%Operating income0.53Net income0.49 +22.9%EPS, diluted7.96 +24.2%Fiscal year 2018Revenue1.89 +16.8%Operating income0.61Net income0.45 −8.4%EPS, diluted7.30 −8.3%Fiscal year 2019Revenue2.16 +14.3%Operating income0.53Net income0.52 +17.1%EPS, diluted9.09 +24.5%Fiscal year 2020Revenue2.36 +9.3%Operating income0.38Net income0.24 −54.4%EPS, diluted4.22 −53.6%Fiscal year 2021Revenue3.09 +30.9%Operating income0.17Net income−0.33 −238.2%EPS, diluted−5.52 −230.8%Fiscal year 2022Revenue3.66 +18.3%Operating income−0.07Net income−0.22EPS, diluted−3.58Fiscal year 2023Revenue3.83 +4.8%Operating income0.58Net income0.41EPS, diluted6.10Fiscal year 2024Revenue4.07 +6.1%Operating income0.72Net income0.56 +35.0%EPS, diluted8.65 +41.8%Fiscal year 2025Revenue4.27 +4.9%Operating income−0.43Net income−0.36 −163.6%EPS, diluted−5.84 −167.5%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 1.49 1.62 1.89 2.16 2.36 3.09 3.66 3.83 4.07 4.27
Growth +8.8% +16.8% +14.3% +9.3% +30.9% +18.3% +4.8% +6.1% +4.9%
Operating income 0.59 0.53 0.61 0.53 0.38 0.17 −0.07 0.58 0.72 −0.43
Net income 0.40 0.49 0.45 0.52 0.24 −0.33 −0.22 0.41 0.56 −0.36
Growth +22.9% −8.4% +17.1% −54.4% −238.2% +35.0% −163.6%
EPS, diluted 6.41 7.96 7.30 9.09 4.22 −5.52 −3.58 6.10 8.65 −5.84
Growth +24.2% −8.3% +24.5% −53.6% −230.8% +41.8% −167.5%

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2016Operating margin39.8%Net margin26.7%Free cash flow margin39.2%Fiscal year 2017Operating margin32.7%Net margin30.1%Free cash flow margin41.0%Fiscal year 2018Operating margin32.5%Net margin23.6%Free cash flow margin41.2%Fiscal year 2019Operating margin24.6%Net margin24.2%Free cash flow margin34.1%Fiscal year 2020Operating margin16.0%Net margin10.1%Free cash flow margin37.4%Fiscal year 2021Operating margin5.5%Net margin−10.7%Free cash flow margin24.3%Fiscal year 2022Operating margin−1.8%Net margin−6.1%Free cash flow margin34.0%Fiscal year 2023Operating margin15.1%Net margin10.8%Free cash flow margin27.9%Fiscal year 2024Operating margin17.6%Net margin13.8%Free cash flow margin33.4%Fiscal year 2025Operating margin−10.1%Net margin−8.3%Free cash flow margin30.4%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin 39.8% 32.7% 32.5% 24.6% 16.0% 5.5% −1.8% 15.1% 17.6% −10.1%
Net margin 26.7% 30.1% 23.6% 24.2% 10.1% −10.7% −6.1% 10.8% 13.8% −8.3%
Free cash flow margin 39.2% 41.0% 41.2% 34.1% 37.4% 24.3% 34.0% 27.9% 33.4% 30.4%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow0.59Capital expenditure−0.01Free cash flow0.58Buybacks−0.28Fiscal year 2017Operating cash flow0.69Capital expenditure−0.03Free cash flow0.66 +14.0%Buybacks−0.10Fiscal year 2018Operating cash flow0.80Capital expenditure−0.02Free cash flow0.78 +17.2%Buybacks−0.52Fiscal year 2019Operating cash flow0.78Capital expenditure−0.04Free cash flow0.74 −5.4%Buybacks−0.30Fiscal year 2020Operating cash flow0.90Capital expenditure−0.02Free cash flow0.88 +20.2%Buybacks−0.15Fiscal year 2021Operating cash flow0.78Capital expenditure−0.03Free cash flow0.75 −15.1%Buybacks0.00Fiscal year 2022Operating cash flow1.27Capital expenditure−0.03Free cash flow1.24 +65.5%Buybacks−0.00Fiscal year 2023Operating cash flow1.09Capital expenditure−0.02Free cash flow1.07 −14.1%Buybacks−0.27Fiscal year 2024Operating cash flow1.40Capital expenditure−0.04Free cash flow1.36 +27.1%Buybacks−0.31Fiscal year 2025Operating cash flow1.36Capital expenditure−0.06Free cash flow1.30 −4.5%Buybacks−0.13
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow 0.59 0.69 0.80 0.78 0.90 0.78 1.27 1.09 1.40 1.36
Capital expenditure −0.01 −0.03 −0.02 −0.04 −0.02 −0.03 −0.03 −0.02 −0.04 −0.06
Free cash flow 0.58 0.66 0.78 0.74 0.88 0.75 1.24 1.07 1.36 1.30
Growth +14.0% +17.2% −5.4% +20.2% −15.1% +65.5% −14.1% +27.1% −4.5%
Buybacks −0.28 −0.10 −0.52 −0.30 −0.15 0.00 −0.00 −0.27 −0.31 −0.13

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash0.37Total debt2.03Net cash (debt)−1.66Shareholders’ equity1.88Debt to equity1.08Fiscal year 2017Cash0.39Total debt1.58Net cash (debt)−1.20Shareholders’ equity2.71Debt to equity0.58Fiscal year 2018Cash0.31Total debt1.60Net cash (debt)−1.29Shareholders’ equity2.76Debt to equity0.58Fiscal year 2019Cash0.64Total debt1.61Net cash (debt)−0.97Shareholders’ equity3.11Debt to equity0.52Fiscal year 2020Cash1.06Total debt2.09Net cash (debt)−1.04Shareholders’ equity3.66Debt to equity0.57Fiscal year 2021Cash0.59Total debt6.05Net cash (debt)−5.46Shareholders’ equity3.97Debt to equity1.53Fiscal year 2022Cash0.88Total debt5.72Net cash (debt)−4.84Shareholders’ equity3.09Debt to equity1.86Fiscal year 2023Cash1.51Total debt5.71Net cash (debt)−4.21Shareholders’ equity3.74Debt to equity1.53Fiscal year 2024Cash2.41Total debt6.11Net cash (debt)−3.70Shareholders’ equity4.09Debt to equity1.49Fiscal year 2025Cash1.39Total debt5.36Net cash (debt)−3.97Shareholders’ equity4.32Debt to equity1.24
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 0.37 0.39 0.31 0.64 1.06 0.59 0.88 1.51 2.41 1.39
Total debt 2.03 1.58 1.60 1.61 2.09 6.05 5.72 5.71 6.11 5.36
Net cash (debt) −1.66 −1.20 −1.29 −0.97 −1.04 −5.46 −4.84 −4.21 −3.70 −3.97
Shareholders’ equity 1.88 2.71 2.76 3.11 3.66 3.97 3.09 3.74 4.09 4.32
Debt to equity 1.08 0.58 0.58 0.52 0.57 1.53 1.86 1.53 1.49 1.24

In billions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Cash flow

In billions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Operations
0.59 0.69 0.80 0.78 0.90 0.78 1.27 1.09 1.40 1.36
Growth +17.0% +15.3% −2.8% +15.9% −13.5% +63.4% −14.1% +27.8% −2.9%
0.01 0.01 0.02 0.02 0.02 0.03 0.03 0.03 0.03 0.04
Investment
−0.01 −0.03 −0.02 −0.04 −0.02 −0.03 −0.03 −0.02 −0.04 −0.06
calc 0.58 0.66 0.78 0.74 0.88 0.75 1.24 1.07 1.36 1.30
Growth +14.0% +17.2% −5.4% +20.2% −15.1% +65.5% −14.1% +27.1% −4.5%
calc 9.42 10.83 12.72 12.79 15.65 12.58 19.87 14.82 20.57 21.27
−1.75 −0.27 −0.39 −0.16 −1.01 −5.21 −0.45 −0.16 −0.51 −1.51
Financing
0.54 −0.41 −0.48 −0.29 0.53 3.97 −0.53 −0.31 0.02 −0.87
−0.28 −0.10 −0.52 −0.30 −0.15 0.00 −0.00 −0.27 −0.31 −0.13

Lines marked calc are worked out here from filed figures; point at one for how. Capital expenditure, dividends and buybacks are shown as money out, so negative.